SIMLANDI
SIMLANDI
Approved
DIN Number
02523965
Drug Class
Human
Market Date
May 19, 2022
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02523965
AIG Number0150364002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADALIMUMABActive
Strength: 80 MG / 0.8 ML
Monograph: ADALIMUMAB